Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED)… (NCT05776953) | Clinical Trial Compass
RecruitingPhase 4
Evaluation of the Effects of Ketorolac Dose on Duration of Analgesia in Emergency Department (ED) Renal Colic Patients
United States86 participantsStarted 2023-12-21
Plain-language summary
This is a prospective interventional study examining the effect of ketorolac at doses of 15mg versus 30 mg for duration of analgesia in emergency department patients with suspected renal colic.
Who can participate
Age range18 Years – 65 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
Patients will be included if they present to the Emergency Department with (all of the following):
* Adult emergency department patients \< 65 years old
* One or more of the following common ED chief complaints associated with the suspected diagnosis of renal colic. These chief complaints include but are not limited to: flank pain, back pain, abdominal pain, left and/or right lower quadrant pain, and/or pelvic pain
* Pain score of 4 or greater on the 0-10 NRS
* Determination of treatment with IV ketorolac
Exclusion Criteria:
Patients will be excluded if any of the following apply:
* Allergy to ketorolac
* Pregnant patients
* Previously received analgesic medications within 4 hours prior to administration of ketorolac in our ED
* Known or stated history of renal insufficiency
* Body weight \< 50 kg
* Age greater than 65 years
* Patients that do no read/write Spanish or English
What they're measuring
1
Change in pain scale post ketorolac administration
Timeframe: At 120 minutes (+/-10 minutes) from medication administration